# Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance

> **NCT03330275** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Visual Performance

## Interventions

- **DEVICE:** Investigational Contact Lens
- **DEVICE:** Commercial ACUVUE OASYS
- **DEVICE:** Commercial ACUVUE OASYS and Spectacles

## Key facts

- **NCT ID:** NCT03330275
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-27
- **Primary completion:** 2017-12-11
- **Final completion:** 2017-12-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03330275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03330275, "Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03330275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*